4SC AG: 4SC AG resolves to issue new shares with expected proceeds of approx. EUR 4 million

Planegg-Martinsried (pta019/11.09.2024/17:40 UTC+2)

The management board of 4SC AG ("4SC") (Frankfurt Stock Exchange, Prime Standard: VSC; ISIN: DE000A3E5C40) today resolved - with the approval of the supervisory board - to implement a capital increase from authorized capital to raise funds to continue its drug development program.

The management board has resolved to increase 4SC's share capital by EUR 792,080 from EUR 10,114,009 to EUR 10,906,089 by issuing 792,080 new no-par value bearer shares from its authorized capital, each with a notional par value of EUR 1.00, against cash contribution.

The new shares will be subscribed by 4SC's main shareholder, Santo Holding (Deutschland) GmbH in full. The subscription price per new share is EUR 5.05. The statutory subscription rights have been excluded pursuant to Sec. 186 Para. 3 sentence 4 of the German Stock Corporation Act (Aktiengesetz). The gross proceeds amount to approx. EUR 4 million.

The capital increase is expected to be registered with the commercial register on or around 17 September 2024. Trading of the new shares on the Frankfurt Stock Exchange is anticipated to commence on 24 September 2024.

—————————————————————————
Information and Explanation of the Issuer to this News:

Jason Loveridge, CEO of 4SC, commented; "The addition of this new investment from our main shareholder provides 4SC with sufficient resources to respond to the EMA's requests for additional information in 2024 with respect to the company's Marketing Authorization Application for resminostat (Kinselby)".

Forward-looking information

Information set forth in this press release contains forward-looking statements, which involve risks and uncertainties. The forward-looking statements contained herein represent the judgement of 4SC as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond 4SC's control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. 4SC expressly disclaims any obligation or undertaking to release any updates or revisions to any such statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

Notice

This ad-hoc release constitutes neither an offer to sell nor a solicitation to buy securities.

In particular, this publication is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, as amended (the "Securities Act") or an exemption from registration. The Shares have not been and will not be registered under the Securities Act.

Neither this ad-hoc release nor any copy of it (nor in whole or in part) may be released, distributed, published or transmitted, directly or indirectly, into the United States, Australia, Canada, Japan, South Africa, or any other jurisdiction where it is unlawful to distribute this announcement. This ad-hoc release does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase or subscribe nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefore.

For further information, please contact:

4SC AG

ir-pr@4sc.com

Optimum Strategic Communications

Nick Bastin, Eleanor Cooper, Vareen Outhonesack

Phone: +44 20 3922 0891

4SC@optimumcomms.com

(end)

Emitter:	4SC AG Fraunhoferstr. 22 82152 Planegg-Martinsried Germany
Contact Person:	Jason Loveridge
Phone:	+49 89 700763-0
E-Mail:	ir-pr@4sc.com
Website:	www.4sc.de
ISIN(s):	DE000A3E5C40 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate